SummaryMany different molecular mechanisms have been associated with PML-RARα-dependent transformation of hematopoietic progenitors. Here, we identified high confidence PML-RARα binding sites in an acute promyelocytic leukemia (APL) cell line and in two APL primary blasts. We found colocalization of PML-RARα with RXR to the vast majority of these binding regions. Genome-wide epigenetic studies revealed that treatment with pharmacological doses of all-trans retinoic acid induces changes in H3 acetylation, but not H3K27me3, H3K9me3, or DNA methylation at the PML-RARα/RXR binding sites or at nearby target genes. Our results suggest that PML-RARα/RXR functions as a local chromatin modulator and that specific recruitment of histone deacetylase a...
SummaryPathogenesis of acute promyelocytic leukemia (APL) has been proposed to involve transcription...
PML-RAR is an oncogenic transcription factor forming in acute promyelocytic leukemias (APL) because ...
The acute promyelocytic leukemia (PML)-retinoic acid receptor alpha (RARalpha) fusion product recrui...
SummaryMany different molecular mechanisms have been associated with PML-RARα-dependent transformati...
Many different molecular mechanisms have been associated with PML-RARa-dependent transformation of h...
SummaryAlthough PML-enforced RARA homodimerization allows PML/RARA to bind DNA independently of its ...
SummaryPML/RARα is of crucial importance in acute promyelocytic leukemia (APL) both pathologically a...
BACKGROUND: Acute promyeloid leukemia (APL) is characterized by the oncogenic fusion protein PML-RAR...
Acute promyelocytic leukemia (APL) is a distinct subtype of acute myeloid leukemia characterized by ...
Acute promyelocytic leukemia (APL) is characterised by the t(15;17)(q22;q21) leading to fusion of PM...
SummaryRARA becomes an acute promyelocytic leukemia (APL) oncogene by fusion with any of five transl...
The retinoic acid receptor alpha (RARA) gene is disrupted by PML/RARA fusion in acute promyelocytic ...
PML-RARα induces a block of hematopoietic differentiation and acute promyelocytic leukemia. This blo...
Acute promyelocytic leukaemia (APL) is a subtype of acute myeloid leukaemia, caused by the t(15;17) ...
<div><p>(A) In the absence of RA, RARα/RXR heterodimers recruit the transcription corepressor (CoR),...
SummaryPathogenesis of acute promyelocytic leukemia (APL) has been proposed to involve transcription...
PML-RAR is an oncogenic transcription factor forming in acute promyelocytic leukemias (APL) because ...
The acute promyelocytic leukemia (PML)-retinoic acid receptor alpha (RARalpha) fusion product recrui...
SummaryMany different molecular mechanisms have been associated with PML-RARα-dependent transformati...
Many different molecular mechanisms have been associated with PML-RARa-dependent transformation of h...
SummaryAlthough PML-enforced RARA homodimerization allows PML/RARA to bind DNA independently of its ...
SummaryPML/RARα is of crucial importance in acute promyelocytic leukemia (APL) both pathologically a...
BACKGROUND: Acute promyeloid leukemia (APL) is characterized by the oncogenic fusion protein PML-RAR...
Acute promyelocytic leukemia (APL) is a distinct subtype of acute myeloid leukemia characterized by ...
Acute promyelocytic leukemia (APL) is characterised by the t(15;17)(q22;q21) leading to fusion of PM...
SummaryRARA becomes an acute promyelocytic leukemia (APL) oncogene by fusion with any of five transl...
The retinoic acid receptor alpha (RARA) gene is disrupted by PML/RARA fusion in acute promyelocytic ...
PML-RARα induces a block of hematopoietic differentiation and acute promyelocytic leukemia. This blo...
Acute promyelocytic leukaemia (APL) is a subtype of acute myeloid leukaemia, caused by the t(15;17) ...
<div><p>(A) In the absence of RA, RARα/RXR heterodimers recruit the transcription corepressor (CoR),...
SummaryPathogenesis of acute promyelocytic leukemia (APL) has been proposed to involve transcription...
PML-RAR is an oncogenic transcription factor forming in acute promyelocytic leukemias (APL) because ...
The acute promyelocytic leukemia (PML)-retinoic acid receptor alpha (RARalpha) fusion product recrui...